Sort by:

select Language:

WHO Guidelines on tuberculosis infection prevention and control, 2019 update

World Health Organization (WHO), (2019)

The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions specific to preventing transmission of Mycobacterium tuberculosis bridging with the core components of infection prevention and control programmes at the national and acute health care facility level

WHO consolidated guidelines on drug-resistant tuberculosis treatment

World Health Organization WHO; Stop TB, (2019)

The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.

Latent TB Infection : Updated and consolidated guidelines for programmatic management

World Health Organization WHO, (2018)

The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The guidelines are to be used primarily in national TB and HIV control programmes, or their equivalents in ministries of health, and for other policy-makers working on TB and HIV and infectious diseases. They are also appropriate for officials in other line ministries with work in the areas of health.

Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis

World Health Organization WHO, (2018)

2nd edition. T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or symptoms of TB in seeking diagnosis, treatment and care; and includes key algorithms and cross-cutting elements that are essential to a patient-centered approach in the cascade of TB care. The Compendium is structured into 33 WHO standards and consolidates all current WHO TB policy recommendations into a single resource, with electronic links to the individual, comprehensive WHO policy guidelines

Mejores prácticas para la atención de pacientes con tuberculosis

G. Williams, E. Alarcón, S. Jittimanee et al., (2017)

Guía para países de bajos ingresos. 2 edición

Field Guide for the Management of Drug-Resistant Tuberculosis

A. Piubello, Eds.: The International Union Against Tuberculosis and Lung Disease, (2018)

A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.

Management of Diabetes Mellitus-Tuberculosis – A Guide to the Essential Practice

Lin Yan, Anthony D Harries, Ajay M V Kumar, et al., Eds.: The International Union Against Tuberculosis and Lung Disease, (2018)

This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation.

Best Practice for the Care of Patients with Tuberculosis: a Guide for Low-Income Countries

G. Williams, E. Alarcón, S. Jittimanee et al., Eds.: The International Union Against Tuberculosis and Lung Disease, (2017)

2nd edition. The practical aspects of TB patient care from the onset of symptoms to the completion of treatment are covered in this guide

Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB)

World Health Organization WHO, (2018)

The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked medicines for all patients with MDR-TB.

81 hits